Hsp90 cleavage by an oxidative stress leads to its client proteins degradation and cancer cell death
Introduction
The heat shock protein 90 (Hsp90) plays a crucial role in the stability of several proteins (like Bcr-Abl, Akt, RIP, mutated p53, etc.) that are essential for malignant transformation [1], [2]. Hsp90 is a conformational flexible protein that associates with a distinct set of co-chaperones depending on nucleotide (ADP or ATP) occupancy of an amino-terminal binding pocket. Nucleotide exchange and ATP hydrolysis drive the so-called Hsp90 chaperone machine to bind co-chaperones as well as client proteins, protecting these latter from proteasomal degradation [3]. The ability of Hsp90 to interact with multiple signaling networks is exploited by cancer cells, in which the expression of Hsp90 is increased [4]. Given the number of key nodal proteins that are Hsp90 clients, its inhibition represents an interesting target for cancer therapies. For instance, the safety evaluation of a small molecule inhibitor of Hsp90, the benzoquinone ansamycin antibiotic 17-allylamino-17-demethoxygeldanamycin (17-AAG), has been recently completed in four phase I clinical studies [5], [6], [7], [8]. In fact, 17-AAG appears to act by suppressing the chaperone function of Hsp90, which causes the degradation of several client proteins.
On the other hand, it has been recently reported that the chaperoning function of Hsp90 may be disrupted by protein cleavage induced by hydrogen peroxide [9], [10] or other reactive oxygen species (ROS) generated by arsenate [11]. The mechanisms underlying such a protein cleavage are still elusive, but due to the major role of Hsp90 in stabilizing key proteins involved in cancer cell survival, we decided to investigate whether an oxidative stress affects Hsp90, inducing the degradation of its client proteins and leading to cancer cell death. The rationale of our approach was that in K562 cells, a human leukemia cell line expressing Bcr-Abl (an Hsp90 client protein), oxidative stress generated by ascorbate-driven menadione redox cycling (ascorbate/menadione), inhibits glycolysis leading to an ATP depletion [12]. Since the assembly of the Hsp90–client protein complexes requires ATP [13], [14], this could represent a new strategy to inhibit Hsp90.
The main finding of this work is that ascorbate/menadione induces an oxidative stress that causes a cleavage of Hsp90, which appears to preferentially affect cancer cells rather than normal cells. Indeed, by comparing a large panel of normal and cancer cell lines, the Hsp90 cleavage by ascorbate/menadione was observed in all tumor cell lines tested but in none of the non-transformed cells. This partial proteolysis disrupts the chaperoning function of Hsp90 leading to degradation of its client proteins: Bcr-Abl, RIP and Akt. The major role of oxidative stress in this process is supported by the fact that both Hsp90 cleavage and Bcr-Abl degradation were observed in K562 cells incubated with another H2O2-generating system (glucose/glucose oxidase) and by the effects of redox-modulators (N-acetylcysteine and aminotriazole). Due to the critical function played by Hsp90 in stabilizing oncogenic proteins in cancer cells, these data suggest that ascorbate/menadione might be of interest in anticancer therapy.
Section snippets
Chemicals and antibodies
Menadione sodium bisulfite, sodium ascorbate, dimethylsulfoxide, N-acetyl-cysteine, glucose oxidase, 3-methyladenine, pepstatin, 17-allylamino-17-demethoxygeldanamycin (17-AAG), nitro-blue-tetrazolium (NBT), 5-bromo-4-chloro-3-indolyl phosphate (BCIP), hydrogen peroxide, antipain and cycloheximide were purchased from Sigma (St. Louis, MO). Iodoacetate was purchased from Acros Organics (Geel, Belgium). Calpeptin was purchased from Calbiochem (San Diego, CA). Polyclonal rabbit primary antibodies
Oxidative stress by ascorbate/menadione induces Hsp90 cleavage
Fig. 1A shows the appearance of an additional Hsp90 protein band of approximately 70 kDa in K562 cells treated with ascorbate/menadione (2 mM/10 μM) suggesting Hsp90 cleavage. In contrast to the ansamycin antibiotic 17-AAG, a well-known Hsp90 inhibitor, the cleavage of Hsp90 induced by ascorbate/menadione was not accompanied by an increase in the Hsp70 levels. In addition, the incubation of cells with cycloheximide (a protein synthesis inhibitor), did not affect the appearance of the low molecular
Discussion
The major finding of this study is that an oxidative stress induces Hsp90 cleavage in cancer cells leading to the degradation of its client proteins. This lethal oxidative injury for cancer cells is caused by the formation of ROS (specially H2O2) that are generated during the menadione redox cycling enhanced by ascorbate [19], [22]. Given that oncogenic transformation is associated with an increased generation of ROS, which renders transformed cells more sensitive to oxidative stress, this
Acknowledgements
The authors thank Isabelle Blave for her excellent technical assistance, Dr. Patrizia Agostinis and Michael DeWaele (KUL) for their valuable help during the LC3 Western blot experiments. This work was supported by grants from the Belgian Fonds National de la Recherche Scientifique (3.4594.04) and by the Fonds Spéciaux de Recherche (FSR) Université Catholique de Louvain. Raphaël Beck is a FRIA recipient and Julien Verrax is a FNRS post-doctoral researcher.
References (39)
- et al.
Hydrogen peroxide signaling through tumor necrosis factor receptor 1 leads to selective activation of c-Jun N-terminal kinase
J Biol Chem
(2003) - et al.
Iron-mediated H2O2 production as a mechanism for cell type-specific inhibition of tumor necrosis factor alpha-induced but not interleukin-1beta-induced IkappaB kinase complex/nuclear factor-kappaB activation
J Biol Chem
(2005) - et al.
Reactive oxygen species-dependent HSP90 protein cleavage participates in arsenical As(+3)- and MMA(+3)-induced apoptosis through inhibition of telomerase activity via JNK activation
Toxicol Appl Pharmacol
(2008) - et al.
Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone
Cell
(1997) - et al.
Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells
Blood
(2007) - et al.
The mechanism of oxidation of aldehydes by glyceralde-hyde-3-phosphate dehydrogenase
J Biol Chem
(1952) - et al.
The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death. Basis for their potential use as coadjuvants in anticancer therapy
Eur J Med Chem
(2003) - et al.
Oxidative stress by ascorbate/menadione association kills K562 human chronic myelogenous leukaemia cells and inhibits its tumour growth in nude mice
Biochem Pharmacol
(2006) - et al.
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate
Cancer Cell
(2006) - et al.
Hip is a pro-survival substrate of granzyme B
J Biol Chem
(2007)